C23H24Cl2N6O2
487.4 g/mol
APIWarning
Momelotinib dihydrochloride
CAS1380317-28-1
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Momelotinib dihydrochloride is a pharmaceutical raw material used as a Janus kinase inhibitor. It is primarily utilized in the manufacturing of medications for myelofibrosis.
Pharmaceutical raw material for Janus kinase inhibitor drugsActive pharmaceutical ingredient in myelofibrosis treatments
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1380317-28-1
Related Compounds
StrongSame Parent
Momelotinib dihydrochloride monohydrate
CAS1841094-17-4
pharmaceutical raw material
StrongSame Parent
Momelotinib
CAS1056634-68-4
pharmaceutical raw material
ReferenceSame Category
Fesoterodinyl (4-Hydroxy-tolterodine phenoxy) Ether
CAS1380491-71-3
pharmaceutical raw material
ReferenceSame Category
Gadovist
CAS138071-82-6
pharmaceutical raw material
ReferenceSame Category
Agomelatine
CAS138112-76-2
pharmaceutical raw material
ReferenceSame Category
Levofloxacin hemihydrate
CAS138199-71-0
pharmaceutical raw material
Referencesame scaffold
4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzoic acid
CAS945749-71-3
pharmaceutical intermediate
Safety Reference
Warning
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
H361Suspected of damaging fertility or the unborn child
H373May cause damage to organs through prolonged or repeated exposure
Identifiers
IUPAC Name
N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide;dihydrochloride
InChIKey
IPNATXQRPWRHKD-UHFFFAOYSA-N
SMILES
C1COCCN1C2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CC=C(C=C4)C(=O)NCC#N.Cl.Cl
Synonyms (11)
- Momelotinib dihydrochloride (USAN)
- CYT387 dihydrochloride
- Momelotinib 2HCl
- Momelotinib HCl
- Momelotinib dihydrochloride